MedTrace Logo

Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG)

NCT05120388 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2024-08-20

No results posted yet for this study

Summary

Gestational diabetes mellitus (GDM) is associated to adverse maternal and neonatal outcomes. The aim of this study is to address whether the addition of extra virgin olive oil to the diet of women with GDM improves maternal triglyceridemia and reduces insulin requirement and diagnosis of diabetes at postnatal reclassification.

Conditions

  • Gestational Diabetes

Interventions

DIETARY_SUPPLEMENT

Extra Virgin Olive Oil Addition

Daily dietary addition of olive oil (three tablespoons)

Sponsors & Collaborators

  • Sociedad Argentina de Diabetes

    collaborator UNKNOWN

  • Center for Pharmacological and Botanical Research

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-11
Primary Completion
2024-04-15
Completion
2024-08-19

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120388 on ClinicalTrials.gov